Harvard Bioscience Inc (HBIO)
2.225
+0.06
(+3.01%)
USD |
NASDAQ |
Nov 22, 11:15
Harvard Bioscience Gross Profit Margin (Quarterly): 58.10% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 58.10% |
| June 30, 2024 | 57.23% |
| March 31, 2024 | 60.26% |
| December 31, 2023 | 57.99% |
| September 30, 2023 | 58.06% |
| June 30, 2023 | 57.97% |
| March 31, 2023 | 61.20% |
| December 31, 2022 | 55.70% |
| September 30, 2022 | 45.21% |
| June 30, 2022 | 56.96% |
| March 31, 2022 | 56.21% |
| December 31, 2021 | 59.17% |
| September 30, 2021 | 54.98% |
| June 30, 2021 | 56.01% |
| March 31, 2021 | 57.18% |
| December 31, 2020 | 57.15% |
| September 30, 2020 | 56.14% |
| June 30, 2020 | 59.45% |
| March 31, 2020 | 54.61% |
| December 31, 2019 | 55.64% |
| September 30, 2019 | 54.63% |
| June 30, 2019 | 53.93% |
| March 31, 2019 | 57.28% |
| December 31, 2018 | 55.35% |
| September 30, 2018 | 55.24% |
| Date | Value |
|---|---|
| June 30, 2018 | 48.71% |
| March 31, 2018 | 49.59% |
| December 31, 2017 | 50.91% |
| September 30, 2017 | 50.76% |
| June 30, 2017 | 47.86% |
| March 31, 2017 | 52.95% |
| December 31, 2016 | 45.83% |
| September 30, 2016 | 46.75% |
| June 30, 2016 | 44.67% |
| March 31, 2016 | 48.01% |
| December 31, 2015 | 45.56% |
| September 30, 2015 | 45.57% |
| June 30, 2015 | 43.73% |
| March 31, 2015 | 44.55% |
| December 31, 2014 | 45.66% |
| September 30, 2014 | 44.96% |
| June 30, 2014 | 45.54% |
| March 31, 2014 | 45.42% |
| December 31, 2013 | 43.25% |
| September 30, 2013 | 44.95% |
| June 30, 2013 | 46.33% |
| March 31, 2013 | 47.00% |
| December 31, 2012 | 47.19% |
| September 30, 2012 | 45.95% |
| June 30, 2012 | 47.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
45.21%
Minimum
Sep 2022
61.20%
Maximum
Mar 2023
56.76%
Average
57.16%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.45% |
| Azenta Inc | 40.82% |
| Bionano Genomics Inc | -139.1% |
| Akoya Biosciences Inc | 62.32% |
| Singular Genomics Systems Inc | -74.14% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.42% |
| Return on Assets | -10.62% |
| Return on Invested Capital | -13.35% |
| Profit Margin (Quarterly) | -21.86% |
| Operating Margin (Quarterly) | -7.72% |
| Return on Net Operating Assets | -11.83% |